Oragenics, Inc.
OGEN · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $0 | $0 | $73 |
| - Cash | $11 | $2 | $3 | $1 |
| + Debt | $0 | $3 | $3 | $0 |
| Enterprise Value | – | $1 | -$1 | $73 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | $0 | -$2 | -$2 | -$3 |
| % Margin | – | – | – | – |
| Net Income | -$3 | -$2 | -$2 | -$3 |
| % Margin | – | – | – | – |
| EPS Diluted | -1.96 | -3.1 | -3.6 | -0.51 |
| % Growth | 36.8% | 13.9% | -605.9% | – |
| Operating Cash Flow | -$3 | -$1 | -$2 | -$2 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$3 | -$1 | -$2 | -$2 |